TRCT
CALC icon

Tower Research Capital (TRC)’s CalciMedica CALC Stock Holding History

Tower Research Capital (TRC)’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.23K Buy
821
+417
+103% +$1.48K ﹤0.01% 4415
2026
Q1 		$1.09K Buy
+404
New +$4.1K ﹤0.01% 4725
2025
Q4 		– Sell
-133
Closed -$2.05K – 5187
2025
Q3 		$2.05K Sell
133
-466
-78% -$6.7K ﹤0.01% 4688
2025
Q2 		$4.79K Buy
599
+3
+0.5% +$26 ﹤0.01% 4267
2025
Q1 		$5.7K Buy
596
+351
+143% +$4.38K ﹤0.01% 4094
2024
Q4 		$6.12K Buy
+245
New +$4.29K ﹤0.01% 4204
2024
Q3 		– Sell
-184
Closed -$4.61K – 5724
2024
Q2 		$4.61K Sell
184
-252
-58% -$6.35K ﹤0.01% 4761
2024
Q1 		$10.9K Buy
436
+153
+54% +$3.5K ﹤0.01% 3630
2023
Q4 		$7.08K Buy
283
+245
+645% +$3.54K ﹤0.01% 4661
2023
Q3 		$955 Sell
38
-338
-90% -$5.61K ﹤0.01% 5445
2023
Q2 		$7.55K Buy
+376
New +$8.22K ﹤0.01% 4556
2022
Q2 		– Sell
-3
Closed – – 6093
2022
Q1 		$0 Sell
3
-31
-91% -$2.95K ﹤0.01% 6113
2021
Q4 		$4K Buy
34
+22
+183% +$4.27K ﹤0.01% 5282
2021
Q3 		$3K Sell
12
-175
-94% -$49.2K ﹤0.01% 5083
2021
Q2 		$71K Buy
187
+1
+0.5% +$328 ﹤0.01% 2719
2021
Q1 		$72K Buy
186
+176
+1,760% +$263K ﹤0.01% 2829
2020
Q4 		$21K Buy
+10
New +$14.8K ﹤0.01% 3831

Other funds holding CALC

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tower Research Capital (TRC)'s CALC Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its CalciMedica (CALC) stake by 103% in Q2 2026, buying an estimated $1.48K and bringing the position to 821 shares worth $4.23K. The position accounts for ﹤0.01% of the portfolio, ranked #4415.

Tower Research Capital (TRC) first reported a position in CALC in Q4 2020 and has held it in 17 quarters since. The position peaked at $72K in Q1 2021. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Tower Research Capital (TRC) held 821 shares of CalciMedica worth $4.23K as of Q2 2026.
  • Tower Research Capital (TRC) bought 417 CalciMedica shares in Q2 2026, an estimated $1.48K.
  • CalciMedica made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4415 holding.
  • Tower Research Capital (TRC) first reported a position in CalciMedica in Q4 2020 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s CalciMedica position peaked at $72K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.